share_log
Reuters ·  May 6 09:33
Krystal Biotech Shares Edges Down 8.8% After Q1 Revenue Miss Expectations
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment